News & Updates
Filter by Specialty:
SHBG levels inversely tied to hypertension development
Levels of sex hormone-binding globulin (SHBG) show an inverse relationship with the development of hypertension and change in blood pressure (BP) levels in middle-aged adults, independent of major risk factors, suggests a recent study.
SHBG levels inversely tied to hypertension development
05 Oct 2023Icodec with app superior to OD analogues in insulin-naive T2D
Once-weekly insulin icodec with a dosing guide app is better than once-daily (OD) basal insulin analogues at reducing glycated haemoglobin (HbA1c) and improving treatment satisfaction and compliance in patients with type 2 diabetes (T2D), a study has shown. In addition, hypoglycaemia rates were low and similar between treatment groups.
Icodec with app superior to OD analogues in insulin-naive T2D
05 Oct 2023Adjuvant trastuzumab for HER2-positive early BC: 9 weeks or 1 year?
For patients with HER2-positive early breast cancer (BC), 1 year of adjuvant trastuzumab remains standard of care (SoC) as noninferiority is not demonstrated for a shortened 9-week course of treatment in the final analysis of the phase III ShortHER trial. However, long-term data from the trial provide reassurance in case early discontinuation is needed in low-risk patients.
Adjuvant trastuzumab for HER2-positive early BC: 9 weeks or 1 year?
05 Oct 2023Increasing BP level in late adolescence ups risk of cardiovascular events
Rising levels of blood pressure (BP), starting at 120/80 mm Hg, during late adolescence contribute to a gradual elevation in the risk of major cardiovascular events, reports a study in Sweden.